These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2596239)

  • 21. [Histomorphological investigations of endometrial carcinoma during progestional treatment with chlormadione acetate (author's transl)].
    Boquoi E; Kreuzer G
    Geburtshilfe Frauenheilkd; 1973 Sep; 33(9):697-708. PubMed ID: 4129072
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of gestagen on uterine adenocarcinoma of the endometrium in the human, with special reference to electron microscope study].
    Hayakawa K; Okudaira Y; Nasu K; Iijima H; Taki I
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 Nov; 20(11):1528-9. PubMed ID: 5752842
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
    Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
    Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.
    Budwit-Novotny DA; McCarty KS; Cox EB; Soper JT; Mutch DG; Creasman WT; Flowers JL; McCarty KS
    Cancer Res; 1986 Oct; 46(10):5419-25. PubMed ID: 3756890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth promotion of human endometrial adenocarcinoma cell line HHUA by prolactin.
    Kimura J; Kato Y; Hirose T; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1779-80. PubMed ID: 3782959
    [No Abstract]   [Full Text] [Related]  

  • 26. Age, menopausal status and DNA-content in endometrial adenocarcinoma.
    Strang P; Stendahl U; Tribukait B; Wagenius G; Boman K
    Anticancer Res; 1989; 9(4):1079-82. PubMed ID: 2817789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the enzyme activities of endometrial carcinoma induced by progestogens.
    Willighagen RG; Thiery M
    J Pathol; 1970 Aug; 101(4):Piv-v. PubMed ID: 5504735
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hormone dependence and steroid receptors in adenocarcinomas of the endometrium].
    Lellouche D; Gairard B; Renaud R
    Rev Fr Gynecol Obstet; 1987 May; 82(5):325-9. PubMed ID: 3602807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progestogen treatment of metastatic cancer of the corpus uteri].
    Jensen TS; Lass F
    Ugeskr Laeger; 1965 Oct; 127(41):1294-7. PubMed ID: 5868039
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis and management of perimenopausal and postmenopausal bleeding.
    Richards-Kustan CJ; Kase NG
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):169-89. PubMed ID: 3306518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer in the older woman: diagnosis and prevention.
    Gambrell RD
    Geriatrics; 1988 Sep; 43(9):27-32, 35-6. PubMed ID: 3044928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progestins in the treatment of patients with endometrial adenocarcinoma.
    Smith JP; Rutledge F; Soffar SW
    Am J Obstet Gynecol; 1966 Apr; 94(7):977-84. PubMed ID: 5910365
    [No Abstract]   [Full Text] [Related]  

  • 36. Histological evaluation of in vitro responses of endometrial adenocarcinoma to progestins and their relation to progesterone receptor levels.
    Holinka CF; Deligdisch L; Gurpide E
    Cancer Res; 1984 Jan; 44(1):293-6. PubMed ID: 6690040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphology and DNA content of endometrial cancer nuclei under progestogen treatment.
    Hustin J
    Acta Cytol; 1976; 20(6):556-8. PubMed ID: 1069452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
    Wang HY; Shen L; Sun Z
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.